-
公开(公告)号:US20230041197A1
公开(公告)日:2023-02-09
申请号:US17253799
申请日:2019-06-19
申请人: Progenity, Inc.
发明人: Mitchell Lawrence Jones , Sharat Singh , Christopher Loren Wahl , Harry Stylli , Kevin David Howe , Arana Perera
摘要: This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with an immunomodulator.
-
公开(公告)号:US11363964B2
公开(公告)日:2022-06-21
申请号:US15940407
申请日:2018-03-29
申请人: Progenity Inc.
摘要: Ingestible devices are disclosed that provide very high localization accuracy for the devices when present in the GI tract of a body. Related systems and methods are also disclosed.
-
公开(公告)号:US20220135666A1
公开(公告)日:2022-05-05
申请号:US16769983
申请日:2018-12-13
申请人: Progenity, Inc.
发明人: Mitchell Lawrence Jones , Sharat Singh , Christopher Loren Wahl , Harry Stylli , Kevin David Howe , Aruna Perera
IPC分类号: C07K16/24 , A61K31/4196 , A61K31/4245 , A61K31/428 , A61K31/436 , A61K31/519 , A61K31/606 , A61K38/08 , A61K38/13 , A61K9/48 , C07K16/28 , A61K9/19 , A61K31/573
摘要: This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with a S1P modulator.
-
公开(公告)号:US20210138213A1
公开(公告)日:2021-05-13
申请号:US16496791
申请日:2018-03-30
申请人: Progenity, Inc.
IPC分类号: A61M31/00 , A61K9/00 , A61P1/04 , C07K16/24 , A61K31/436 , A61K9/48 , C07K16/28 , A61K38/13 , C12N15/113
摘要: This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with an immune modulatory agent (e.g., a CD40/CD40L inhibitor).
-
公开(公告)号:US20200245897A1
公开(公告)日:2020-08-06
申请号:US16839107
申请日:2020-04-03
申请人: Progenity, Inc.
发明人: Mitchell Lawrence Jones , Christopher Loren Wahl , Gene Alan Wey , Aaron Olafur Laurence Philippsen , Mark Sasha Drlik , Iman Niknia
摘要: Ingestible devices capable of delivering a dispensable substance, such as, for example, a therapeutic agent, as well as related components, systems and methods, are disclosed. A removably attachable storage reservoir configured to be used with an ingestible device and capable of storing dispensable substance, such as, for example, a therapeutic agent, as well as related components, systems and methods, are also disclosed.
-
公开(公告)号:US20200221954A1
公开(公告)日:2020-07-16
申请号:US16827807
申请日:2020-03-24
申请人: Progenity, Inc.
IPC分类号: A61B5/00 , A61B10/00 , A61K45/06 , A61K49/00 , C12M1/00 , C12N1/20 , C12Q1/04 , C12Q1/06 , C12Q1/10 , G01N1/10 , G01N1/20 , G01N1/38 , G01N21/76 , G01N33/487 , G01N33/483 , G01N33/58 , A61B5/07
摘要: The present disclosure relates to gastrointestinal (GI) tract detection methods, devices and systems.
-
公开(公告)号:US10588608B2
公开(公告)日:2020-03-17
申请号:US15680430
申请日:2017-08-18
申请人: Progenity Inc.
发明人: Mitchell Lawrence Jones , Christopher Loren Wahl , Aaron Olafur Laurence Philippsen , Nicholas David Allan , Mark Sasha Drlik , Ryan Paul McGuinness , Sharat Singh , Robert S. Magyar
摘要: Sampling systems that include an absorbent material a preservative, such as an analyte preservative, as well as related materials and methods, are disclosed.
-
公开(公告)号:US20180206769A1
公开(公告)日:2018-07-26
申请号:US15835303
申请日:2017-12-07
申请人: Progenity Inc.
发明人: Brian Pak , John Mitchell McLean , Paul Timothy Smith , Mitchell Lawrence Jones , Christopher Loren Wahl
IPC分类号: A61B5/1455 , A61B5/145 , A61B5/00 , G01N33/483 , G01N33/487
摘要: The present disclosure relates to gastrointestinal (GI) tract detection methods, devices and systems.
-
公开(公告)号:US20220249814A1
公开(公告)日:2022-08-11
申请号:US17295277
申请日:2019-11-19
申请人: PROGENITY, INC.
发明人: Jeffrey A. Shimizu , Mitchell Lawrence Jones , Mark Sasha Drlik , Iman Niknia , Nathan John Muller , Tuyen Nguyen , Christopher Loren Wahl , Edward Mudge , Nicholas Mark Salt , Nia Eleri Stevens , Stuart Robert Abercrombie , Christopher Ian Bunce , Nelson Quintana
摘要: This disclosure features methods and devices for treating diseases with orally-delivered biotherapeutics.
-
公开(公告)号:US11134889B2
公开(公告)日:2021-10-05
申请号:US16466134
申请日:2017-12-14
申请人: Progenity, Inc.
IPC分类号: A61B5/00 , A61B5/07 , A61K9/00 , A61K9/48 , A61K9/50 , A61K31/436 , C07K16/24 , C07K16/28 , C12N15/113
摘要: This disclosure features methods and compositions for treating diseases of the gastrointestinal tract with a SMAD7 inhibitor.
-
-
-
-
-
-
-
-
-